ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 161 filers reported holding ANTARES PHARMA INC in Q4 2019. The put-call ratio across all filers is 5.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $79,000 | +1.3% | 19,231 | -11.8% | 0.00% | – |
Q4 2021 | $78,000 | +32.2% | 21,810 | +35.2% | 0.00% | – |
Q3 2021 | $59,000 | +9.3% | 16,128 | +30.4% | 0.00% | – |
Q2 2021 | $54,000 | -60.6% | 12,367 | -78.7% | 0.00% | – |
Q1 2020 | $137,000 | -53.1% | 58,136 | -6.5% | 0.00% | – |
Q4 2019 | $292,000 | +65.9% | 62,167 | +18.5% | 0.00% | – |
Q3 2019 | $176,000 | +12.1% | 52,478 | +10.0% | 0.00% | – |
Q2 2019 | $157,000 | +12.9% | 47,698 | +3.8% | 0.00% | – |
Q1 2019 | $139,000 | – | 45,933 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |